143 related articles for article (PubMed ID: 35098039)
1. The EHA Research Roadmap: Transfusion Medicine.
Stanworth SJ; Brand A; Kaveri SV; Vrielink H; Greinacher A; Domanović D; von Lindern M; Allard S; Bayry J; Bohonek M; Buser A; Claas FHJ; Knutson F; Lozano M; Olsson ML; Pirenne F; Rebulla P; So-Osman C; Tissot JD; Toye AM; Ushiro-Lumb I; van den Akker E; Zeerleder S
Hemasphere; 2022 Feb; 6(2):e670. PubMed ID: 35098039
[No Abstract] [Full Text] [Related]
2. The EHA Research Roadmap: Blood Coagulation and Hemostatic Disorders.
Eichinger S; Morange PE; Cattaneo M; Fretigny M; Rauch A; van Hylckama Vlieg A; Trégouët DA; Ruf W; Levi M; Páramo JA; van der Poll T; Kyrle PA; Garagiola I; Peyvandi F
Hemasphere; 2021 Oct; 5(10):e643. PubMed ID: 34522845
[No Abstract] [Full Text] [Related]
3. The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies.
Einsele H; Briones J; Ciceri F; García Cadenas I; Falkenburg F; Bolaños N; Heemskerk HMM; Houot R; Hudecek M; Locatelli F; Morgan K; Morris EC; O'Dwyer M; Sierra JG; van den Brink M; van de Loosdrecht AA
Hemasphere; 2021 Oct; 5(10):e642. PubMed ID: 34522844
[No Abstract] [Full Text] [Related]
4. The European Hematology Association Roadmap for European Hematology Research: a consensus document.
Engert A; Balduini C; Brand A; Coiffier B; Cordonnier C; Döhner H; de Wit TD; Eichinger S; Fibbe W; Green T; de Haas F; Iolascon A; Jaffredo T; Rodeghiero F; Salles G; Schuringa JJ;
Haematologica; 2016 Feb; 101(2):115-208. PubMed ID: 26819058
[TBL] [Abstract][Full Text] [Related]
5. The European Hematology Association: strengthening hematology in Europe and beyond.
Foà R
Expert Rev Hematol; 2011 Apr; 4(2):133-6. PubMed ID: 21495922
[TBL] [Abstract][Full Text] [Related]
6. Proceedings from the 1st Insights in Hematology Symposium, Cluj-Napoca, Romania March 11-12, 2016.
Bojan A; Berindan-Neagoe I; Ciurea S; Dima D; Fuji S; Ghiaur G; Grewal R; Mccormack E; Tanase A; Trifa A; Tomuleasa C
Rom J Intern Med; 2016 Sep; 54(3):157-160. PubMed ID: 27658163
[TBL] [Abstract][Full Text] [Related]
7. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
8. Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations.
Rejeski K; Subklewe M; Aljurf M; Bachy E; Balduzzi A; Barba P; Bruno B; Benjamin R; Carrabba MG; Chabannon C; Ciceri F; Corradini P; Delgado J; Di Blasi R; Greco R; Houot R; Iacoboni G; Jäger U; Kersten MJ; Mielke S; Nagler A; Onida F; Peric Z; Roddie C; Ruggeri A; Sánchez-Guijo F; Sánchez-Ortega I; Schneidawind D; Schubert ML; Snowden JA; Thieblemont C; Topp M; Zinzani PL; Gribben JG; Bonini C; Sureda A; Yakoub-Agha I
Blood; 2023 Sep; 142(10):865-877. PubMed ID: 37300386
[TBL] [Abstract][Full Text] [Related]
9. EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update.
Iolascon A; De Franceschi L; Muckenthaler M; Taher A; Rees D; de Montalembert M; Rivella S; Eleftheriou A; Cappellini MD
Hemasphere; 2019 Jun; 3(3):e208. PubMed ID: 31723835
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in hematology: an update from the 16th Congress of the EHA.
O'Neill T
Expert Rev Hematol; 2011 Dec; 4(6):587-9. PubMed ID: 22077521
[TBL] [Abstract][Full Text] [Related]
11. The EHA Research Roadmap: Infections in Hematology.
Cordonnier C; Ljungman P; Cesaro S; Hirsch HH; Maschmeyer G; von Lilienfeld-Toal M; Vehreschild M; Mikulska M; Emonts M; Gennery AR; Neofytos D; Bochud PY; Einsele H; Maertens J
Hemasphere; 2021 Dec; 5(12):e662. PubMed ID: 34877477
[No Abstract] [Full Text] [Related]
12. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
13. An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHA.
Rejeski K; Greco R; Onida F; Sánchez-Ortega I; Bonini C; Sureda A; Gribben JG; Yakoub-Agha I; Subklewe M
Hemasphere; 2023 May; 7(5):e889. PubMed ID: 37125259
[TBL] [Abstract][Full Text] [Related]
14. Research opportunities in transfusion medicine.
Silberstein LE; Toy P
JAMA; 2001 Feb; 285(5):577-80. PubMed ID: 11176862
[TBL] [Abstract][Full Text] [Related]
15. Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group.
Spanjaart AM; Ljungman P; de La Camara R; Tridello G; Ortiz-Maldonado V; Urbano-Ispizua A; Barba P; Kwon M; Caballero D; Sesques P; Bachy E; Di Blasi R; Thieblemont C; Calkoen F; Mutsaers P; Maertens J; Giannoni L; Nicholson E; Collin M; Vaz CP; Metafuni E; Martinez-Lopez J; Dignan FL; Ribera JM; Nagler A; Folber F; Sanderson R; Bloor A; Ciceri F; Knelange N; Ayuk F; Kroger N; Kersten MJ; Mielke S
Leukemia; 2021 Dec; 35(12):3585-3588. PubMed ID: 34750508
[No Abstract] [Full Text] [Related]
16. [Finding the best option for me as a doctor].
Henzan T
Rinsho Ketsueki; 2021; 62(7):830-834. PubMed ID: 34349068
[TBL] [Abstract][Full Text] [Related]
17. Complex Transfusion Issues in Pediatric Hematopoietic Stem Cell Transplantation.
Webb J; Abraham A
Transfus Med Rev; 2016 Oct; 30(4):202-8. PubMed ID: 27439965
[TBL] [Abstract][Full Text] [Related]
18. The EHA Research Roadmap: Malignant Lymphoid Diseases.
Dreyling M; André M; Gökbuget N; Tilly H; Jerkeman M; Gribben J; Ferreri A; Morel P; Stilgenbauer S; Fox C; Maria Ribera J; Zweegman S; Aurer I; Bödör C; Burkhardt B; Buske C; Dollores Caballero M; Campo E; Chapuy B; Davies A; de Leval L; Doorduijn J; Federico M; Gaulard P; Gay F; Ghia P; Grønbæk K; Goldschmidt H; Kersten MJ; Kiesewetter B; Landman-Parker J; Le Gouill S; Lenz G; Leppä S; Lopez-Guillermo A; Macintyre E; Mantega MVM; Moreau P; Moreno C; Nadel B; Okosun J; Owen R; Pospisilova S; Pott C; Robak T; Spina M; Stamatopoulos K; Stary J; Tarte K; Tedeschi A; Thieblemont C; Trappe RU; Trümper LH; Salles G
Hemasphere; 2022 Jun; 6(6):e726. PubMed ID: 35620592
[No Abstract] [Full Text] [Related]
19. The EHA Research Roadmap: Malignant Myeloid Diseases.
Döhner H; Malcovati L; Ossenkoppele GJ; Hochhaus A; Maria Vannucchi A; Bullinger L; Cervantes F; Craddock C; de Witte T; Döhner K; Dombret H; Fenaux P; Geissler J; Germing U; Guilhot F; Harrison C; Hellström-Lindberg E; Passamonti F; Sierra J; Skoda R; Wierzbowska A
Hemasphere; 2021 Sep; 5(9):e635. PubMed ID: 34476345
[No Abstract] [Full Text] [Related]
20. Current and future commitment to hematology research.
Peterson CM; Harvath L
Hematol Oncol Clin North Am; 2004 Dec; 18(6):1215-34, vii. PubMed ID: 15511613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
